VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 115 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $5,220,000,000 | +42962.2% | 309,800 | -61.2% | 0.78% | -62.5% |
Q4 2017 | $12,122,000 | +36.1% | 797,531 | +60.3% | 2.07% | +19.3% |
Q3 2017 | $8,906,000 | -75.5% | 497,531 | -77.7% | 1.73% | -73.4% |
Q2 2017 | $36,385,000 | +16.4% | 2,232,238 | 0.0% | 6.52% | +5.0% |
Q1 2017 | $31,251,000 | -2.5% | 2,232,238 | +11.1% | 6.21% | -5.8% |
Q4 2016 | $32,060,000 | -28.8% | 2,010,000 | -25.7% | 6.59% | -42.7% |
Q3 2016 | $45,030,000 | +48.7% | 2,706,134 | +0.0% | 11.48% | +32.5% |
Q2 2016 | $30,277,000 | +32.6% | 2,705,758 | -0.9% | 8.67% | +5.8% |
Q1 2016 | $22,833,000 | +16.8% | 2,731,210 | +30.1% | 8.19% | -0.1% |
Q4 2015 | $19,552,000 | +1.1% | 2,100,101 | +22.5% | 8.20% | +7.2% |
Q3 2015 | $19,345,000 | +7.8% | 1,715,000 | +21.3% | 7.65% | +9.4% |
Q2 2015 | $17,939,000 | +38.9% | 1,413,599 | +1.8% | 6.99% | +23.0% |
Q1 2015 | $12,914,000 | – | 1,388,599 | – | 5.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |